New York, NY -- (SBWIRE) -- 01/21/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: ArQule, Inc.(NASDAQ:ARQL),Magnum Hunter Resources Corp(NYSE:MHR),Idenix Pharmaceuticals Inc(NASDAQ:IDIX),JetBlue Airways Corporation(NASDAQ:JBLU)
ArQule, Inc.(NASDAQ:ARQL) reported gain 6.78% and closed at $2.52 with the total traded volume of 4.21M shares. Its market capitalization is $158.01M. The stock has a 52-week high price of 3.10 and its 52-week low was recorded at $1.91.
ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. It employs technologies, such as its ArQule Kinase Inhibitor Platform to design and develop drugs.
What ARQL Charts Are Signaling for Traders? Find Out Here
Magnum Hunter Resources Corp(NYSE:MHR) loss -1.48% and ended at $8.00.The total traded volume was 4.16M shares and market capitalization arrived at $1.37B. The stock has a 52-week high price of $8.20 and its 52-week low was recorded at $2.37, while during last trade its minimum price was $7.85 and it gained the highest price of $8.19.
Magnum Hunter Resources Corporation (Magnum Hunter) is an independent oil and gas company engaged in the exploration for and the exploitation, acquisition, development and production of crude oil, natural gas and natural gas liquids, primarily in the states of West Virginia, Ohio, Texas, Kentucky and North Dakota and in Saskatchewan, Canada.
Is MHR Buy After The Recent Price Movement? Find Out Here
Idenix Pharmaceuticals Inc(NASDAQ:IDIX)’s reported the increase of 17.11% to close at $8.01 with the overall traded volume of 4.00M shares. Its market capitalization on last close reached to $1.07 billion. Its intraday-low price was $6.70 and its hit its day's highest price at $8.45.
Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France.
Should IDIX a Buy or Sell Now? Find Out Here
JetBlue Airways Corporation(NASDAQ:JBLU) plunged -0.67% settle at $8.94. Its total traded volume during last trading session was 3.91M shares. The overall market worth of this company is about $2.51B. The 52 week range of the stock remained $5.70 - $9.22, while its day's lowest price was $8.92 and its hit its day's highest price at $9.10.
JetBlue Airways Corporation (JetBlue) is a passenger airline that operates primarily on point-to-point routes with its fleet of 120 Airbus A320 aircraft and 49 EMBRAER 190 aircraft.
What JBLU Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)